AlloOnc Corporation logo

AlloOnc Corporation

Over 90% of all cancer mortalities result from spreading or recurrence, called metastases. Yet, for most cancer types, treatments are ineffective against metastatic cancer cells. Our product, a proprietary "smart" anti-cancer cellular therapeutic, called Mesenkillers™ (MSK) is designed to halt the metastatic process. MSK are engineered stem cells that innately target the tumor bed, confront the specific cancer cells scientists have shown are responsible for metastases, and will only deploy their active molecule when signaled by these cancer cells.

0
Management
0
Technology
0
Deals/Partnering
0
Research Pipeline
0
Funding
BioStartup's Score 0 / 50

KEY DETAILS

Websitehttp://www.alloonc.com
Founded2013
Disease Focus
Development Stage
STOCK CODENon Listed
Address
722 WALNUT ST. APT 615, KANSAS CITY 64106
Missouri
United States
Email
Contact Number

[atom_linkedin linkedin_option=”CompanyInsider” linkedin_id=”https://www.linkedin.com/company/alloonc-corporation” connections=”true” suffix=””]